Bristol-Myers Squibb

Courtesy of Bristol-Meyers Squibb
  • Previous Rank
    168
  • Revenues ($M)
    19427
  • Revenue Percent Change
    17.3
  • Profits ($M)
    4457
  • Profits Percent Change
    184.8
  • Assets ($M)
    33707
  • Employees
    25000
  • Market Value — as of March 31, 2017 ($M)
    89591

The biopharmaceutical company manufactures medicines for Alzheimer's, dementia, pyschiatric disorders, cardiovascular, diabetes, oncology, and hepatitis.

Company Info

CEOGiovanni Caforio
CEO TitleChief Executive Officer & Director
SectorHealth Care
IndustryPharmaceuticals
HQ LocationNew York, NY
Websitewww.bms.com
Years on Fortune 500 List23
Employees25,000

Key Financials (Last Fiscal Year)

Revenues ($M)$19,427
Profits ($M)$4,457
Assets ($M)$33,707
Total Stockholder Equity ($M)$16,177
Market Value — as of March 31, 2017 ($M)$89,591

Profit Ratios

Profit as % of Revenues22.9%
Profits as % of Assets13.2%
Profits as % of Stockholder Equity27.6%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)3
EPS % Change (from 2015)184.9%
EPS % Change (5 year annual rate)4.2%
EPS % Change (10 year annual rate)12.6%

Total Return

Total Return to Investors (2016)-13%
Total Return to Investors (5 year, annualized)14%
Total Return to Investors (10 year, annualized)12.7%